Natasha Persaud, Author at Cancer Therapy Advisor

Investigators concluded that pN1 RCC could be stratified into pN1 and pN2, with pN2 conferring a poor prognosis comparable to that of non-metastatic stage IV pN0 disease.

Bladder Cancer

Aortic Calcification Ups Risk for Acute Kidney Injury After Radical Cystectomy

By

Natasha Persaud

March 14, 2023

Aortic calcification may lead to arterial degradation that increases the risk for acute kidney injury, according to investigators.

Urologic Cancers

Opioid Prescription Can Be Eliminated After Urologic Cancer Surgery

By

Natasha Persaud

February 24, 2023

A protocol for eliminating routine opioid prescription after major urologic cancer surgery was both safe and successful, according to researchers.

Renal Cell Carcinoma

Partial Nephrectomy Linked to Lower Risk of Early, Not Advanced, CKD in RCC

By

Natasha Persaud

January 31, 2023

The decision to undergo partial instead of radical nephrectomy should be individualized, according to investigators.

Prostate Cancer

Prostate Cancer Survival Slightly Lower With Active Surveillance

By

Natasha Persaud

January 13, 2023

Investigators examined prostate cancer survival after active surveillance vs treatment among the male population in Ontario, Canada.

Bladder Cancer

Efficacy of NMIBC Treatments After BCG Failure Characterized

By

Natasha Persaud

December 21, 2022

A systematic review evaluated current and investigational intravesical and systemic therapies for NMIBC after BCG failure, including chemotherapy, immunotherapy, combination therapy, hyperthermia, and novel biologic agents.